Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun Ma

Showing results (451-460 of 562) with videos related to

Pageof 57
Sort By:
Clinical and Translational Medicine|June 9, 2020
Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasmsTing-Juan Zhang, Zi-Jun Xu, Yu Gu, et al.
Journal of Cellular Physiology|August 5, 2017
Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemiaJing-Dong Zhou, Jiang Lin, Ting-Juan Zhang, et al.
British Journal of Haematology|June 24, 2019
Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemiaYing-Jung Huang, Ming-Chung Kuo, Hung Chang, et al.
Annals of Surgical Oncology|February 13, 2021
The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular SubtypeJia-Chun Ma, Xiao-Rong Zhong, Ting Luo, et al.
Cancer Medicine|September 6, 2019
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemiaGuo-Kang Sun, Li-Juan Tang, Jing-Dong Zhou, et al.
Clinical Biochemistry|February 12, 2013
SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemiaJing Yang, Jun Qian, Dong-ming Yao, et al.
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|June 20, 2014
[Screening active components in compound danshen based on PXR-CYP3A4: an experimental study]Yong Xiao, Zeng-chun Ma, Yu-gaung Wang, et al.
Cell Death & Disease|November 21, 2020
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromesJing-Dong Zhou, Ting-Juan Zhang, Zi-Jun Xu, et al.
Leukemia & Lymphoma|October 28, 2014
Clinical significance of reduced SFRP1 expression in acute myeloid leukemiaCui An, Hong Guo, Xiang-mei Wen, et al.
Taiwanese Journal of Obstetrics & Gynecology|April 11, 2008
Comparison of whole genome amplification methods for further quantitative analysis with microarray-based comparative genomic hybridizationYun-Shien Lee, Chi-Neu Tsai, Chia-Lung Tsai, et al.
Pageof 57

Showing results (451-460 of 562) with videos related to

Sort By:
Pageof 57
Clinical and Translational Medicine|June 9, 2020
Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasmsTing-Juan Zhang, Zi-Jun Xu, Yu Gu, et al.
Journal of Cellular Physiology|August 5, 2017
Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemiaJing-Dong Zhou, Jiang Lin, Ting-Juan Zhang, et al.
British Journal of Haematology|June 24, 2019
Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemiaYing-Jung Huang, Ming-Chung Kuo, Hung Chang, et al.
Annals of Surgical Oncology|February 13, 2021
The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular SubtypeJia-Chun Ma, Xiao-Rong Zhong, Ting Luo, et al.
Cancer Medicine|September 6, 2019
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemiaGuo-Kang Sun, Li-Juan Tang, Jing-Dong Zhou, et al.
Clinical Biochemistry|February 12, 2013
SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemiaJing Yang, Jun Qian, Dong-ming Yao, et al.
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|June 20, 2014
[Screening active components in compound danshen based on PXR-CYP3A4: an experimental study]Yong Xiao, Zeng-chun Ma, Yu-gaung Wang, et al.
Cell Death & Disease|November 21, 2020
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromesJing-Dong Zhou, Ting-Juan Zhang, Zi-Jun Xu, et al.
Leukemia & Lymphoma|October 28, 2014
Clinical significance of reduced SFRP1 expression in acute myeloid leukemiaCui An, Hong Guo, Xiang-mei Wen, et al.
Taiwanese Journal of Obstetrics & Gynecology|April 11, 2008
Comparison of whole genome amplification methods for further quantitative analysis with microarray-based comparative genomic hybridizationYun-Shien Lee, Chi-Neu Tsai, Chia-Lung Tsai, et al.
Pageof 57